Search

Unnecessary confusion still surrounds the use of combined hormonal contraceptives (CHCs) in the setting of migraine with aura (MwA). Clearing this confusion is a key issue for headache specialists, since most women with migraine have menstrual-related migraine (MRM), and some CHCs can prevent this particularly severe migraine. Their use, however, is still restricted by current guidelines due to concerns of increased stroke risk - concerns that originated over half a century ago in the era of high dose contraceptives. Yet studies consistently show that stroke risk is not increased with today's very low dose CHCs containing 20-25 µg ethinyl estradiol (EE), and continuous ultra low-dose formulations (10-15 µg EE) may even reduce aura frequency, thereby potentially decreasing stroke risk. This article clarifies the stroke risk of CHCs and examines their impact on migraine. It also examines how stroke risk is altered by the estrogen content of the CHC, by contributing factors such as smoking, age and hypertension, and by aura frequency. And finally, it puts these risks into a meaningful context with a risk/benefit assessment. [ABSTRACT FROM AUTHOR]

An editorial is presented on the approach on understanding latitudinal differences in migraine epidemiology. It expresses the view that the philosophy of migraine affects the way individuals and the society respond to the condition at the same time. It notes flexibility, adaptability, analysis, expectations, decision making, and locus of control are all dependent on how the condition is viewed.

An editorial is presented on anticipating how Ramadan fasting will affect migraine. Topics include degree of the unmet medical need in people with post-traumatic headache (PTH) is staggering; and PTH often provides essential information to help inform prognosis and guide management and develop new treatment options with Calcitonin gene-related peptide (CGRP).

The author reflects on a study about the effects of injury types on the persistent posttraumatic headaches and functioning among veterans. The subjects were enrolled in a randomized controlled trial of cognitive behavior therapy as treatment of posttraumatic headache. Also cited are the categories of injury mechanisms like blast, blunt and both, and other topics like blast injuries, loss of consciousness (LOC), and posttraumatic stress disorders (PTSD).

An introduction is presented in which the editor discusses the various topics within the issue, including diversity, equity and inclusion (DEI) in headache medicine, the research on African American men in headache medicine, and migraine.

The author discusses about predatory journals. The author defines predatory journals to include aggressive recruitment emails, unrealistic promises regarding publication, and worthless peer review. He explains why problematic journals are problematic and why they exist. He also discusses how to spot a predatory journal and what to do with them.

An editorial is presented on the current state of cluster headache genetics. The article discusses that the authors conduct a systematic review to identify cluster headache genetic studies between 2001 and 2020; and the single nucleotide polymorphism (SNP) had to be investigated in at least two study populations, meaning every gene in the meta-analysis has been verified at least once.

An editorial is presented on the unmet need of headache medicine grand rounds education in neurology. The article discusses that Headache disorders are among the most common and disabling disorders worldwide, accounting for more disability-adjusted life years than all other neurological disorders combined; and this burden is largely attributed to migraine, which is the third leading cause of disability in people under the age of 50.

The article focuses on the journal manuscripts evaluation through the software CrossCheck for checking the validity of the submissions. It discusses how plagiarism affect the journal quality and the reader's trust in the journal especially when it leads to unnecessary duplication in the journal. It also talks about how not only non-native English speakers are susceptible to lifting phrases and plagiarize the content, but also native speakers plagiarize.

The article focuses on issues of hacking in headache research, along with methods authors of Headache manuscripts can use for preventing hacking in their own work. Topics discussed include developing a specific hypothesis for the same; reviewing the data collected for the same; and understanding the problem created by hacking.

The authors reflect on the significance of a study of the neural mechanisms underlying cognitive behavioral therapy (CBT) in children and adolescents with migraine. Topics discussed include the recommendation of CBT with amitriptyline by the American Headache Society and American Academy of Neurology, factors that contribute to the reluctance patients and physicians to use CBT, and potential for CBT to be customized to individual patients.

An introduction is presented in which the editor discusses articles in the issue on topics including intravenous dihydroergotamine for pediatric headache, and new daily persistent headache.

The authors reflect on the updated standardized guidelines for the management of patients with headache disorders that was issued by the American Headache Society (AHS) as of April 2021. Other topics include the three levels of guidelines, namely, opinion pieces, evidence-based guidelines, and position statements/white papers, as well as AHS' collaboration with the American Academy of Neurology (AAN) in developing the guidelines.

The author reflects on the treatments for headache, including migraine, in the emergency department (ED). Other topics include how non-headache specialists in the ED should treat headache like screening for secondary headache, as well as the various factors affecting acute treatment of migraine like length of attack, severity of migraine, and the presence of other symptoms like allodynia.

An introduction is presented in which the editors discuss the various topics within the issue like pediatric headache disorders, noninvasive acute and preventive treatment modalities in children and adolescents with headache disorders, and the use of Onabotulinumtoxin A to treat chronic migraine.

Wiley has updated its publishing ethics guidelines, first published in 2006. The new guidelines provide guidance, resources, and practical advice on ethical concerns that arise in academic publishing for editors, authors, and researchers, among other audiences. New guidance is also included on whistle blowers, animal research, clinical research, and clinical trial registration, addressing cultural differences, human rights, and confidentiality. The guidelines are uniquely interdisciplinary, and were reviewed by 24 editors and experts chosen from the wide range of communities that Wiley serves. They are also published in Advanced Materials, International Journal of Clinical Practice, Annals of the New York Academy of Sciences, Social Science Quarterly, and on the website . [ABSTRACT FROM AUTHOR]

The article presents an analysis of the efficacy of ubrogepant based on prior experience with triptans. It found that the efficacy and tolerability of ubrogepant did not differ for three classifications of participants based on historical experience with triptans. It mentions the heterogeneity of treatment effect analysis methods used here are very relevant to current headache medicine.

The article focuses on migraine knowledge gaps among women's healthcare providers. Topics discussed include the preventive treatments prescribed for migraine such as antidepressants and anticonvulsants; hormone therapies in reducing migraine and migraine as the leading cause of visits to the emergency room among women of childbearing age.

The article presents the discussion on reviewers playing a critical role in the full and fair evaluation of papers expressing the gratitude to the individuals including Elizabeth Ackley, Michael Marmura, and Jessica Ailani.

Background A case report is a narrative that describes, for medical, scientific, or educational purposes, a medical problem experienced by one or more patients. Case reports written without guidance from reporting standards are insufficiently rigorous to guide clinical practice or to inform clinical study design. Objective Develop, disseminate, and implement systematic reporting guidelines for case reports. Methods We used a three-phase consensus process consisting of (1) pre-meeting literature review and interviews to generate items for the reporting guidelines, (2) a face-to-face consensus meeting to draft the reporting guidelines, and (3) post-meeting feedback, review, and pilot testing, followed by finalization of the case report guidelines. Results This consensus process involved 27 participants and resulted in a 13-item checklist-a reporting guideline for case reports. The primary items of the checklist are title, key words, abstract, introduction, patient information, clinical findings, timeline, diagnostic assessment, therapeutic interventions, follow-up and outcomes, discussion, patient perspective, and informed consent. Conclusions We believe the implementation of the CARE (CAse REport) guidelines by medical journals will improve the completeness and transparency of published case reports and that the systematic aggregation of information from case reports will inform clinical study design, provide early signals of effectiveness and harms, and improve healthcare delivery. [ABSTRACT FROM AUTHOR]

The article offers information on manuscripts published in peer review journals, other than "Headache: The Journal of Head & Face Pain." One concerns a population-based study of migraine and cardiovascular disease. Another deals with sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. Another one is about rates, predictors, and consequences of remission from chronic migraine to episodic migraine.

Universal definitions of ethical issues related to medical publishing have remained somewhat elusive. Training in the art of writing for medical journals is inconsistent and most commonly informal, involving collaborative efforts between mentors and students. This approach inadvertently may perpetuate erroneous assumptions as to what constitutes acceptable behavior. In contrast to instruction on composition, ethical considerations related to the publication of a paper are likely to receive little attention. Even so, consequent to the ever-increasing scrutiny from the media and government agencies, journals are recognizing the need for greater transparency in peer review and are thus more inclined to enforce ethical standards. Understanding that some apparent ethical contraventions are the result of confusion or a lack of knowledge, some journals are assuming the responsibility of educating their community about ethical issues in publishing. This paper reviews the key ethical issues (eg, authorship criteria, conflicts of interest, redundant publication, data access and biases in data reporting, image manipulation) that authors should consider before submitting a manuscript. It also surveys some of the policies of the most highly cited clinical medical journals. In the future, authors can anticipate that their submissions will be required to meet an expanding array of ethical standards. [ABSTRACT FROM AUTHOR]

An editorial is presented the American eadache society and the new women's health research award. Topics include the association with adult revictimization, the role of emotional abuse in chronic migraine, and the relationship of childhood abuse and comorbid pain conditions; a problem predominantly affecting women and girls, and its association with migraine and its comorbidities, including depression and anxiety.

The article present appointment of Dr. Amy Gelfand, as an editor-in-chief of headache: the journal of head and face pain.

The article focuses on migraine is a plausible candidate for impacting the accident rate, as its cognitive, visual, and vestibular symptoms can all affect the ability to drive. It mentions the accident rate seems to double in migraine sufferers, but it is unclear to what extent this is due to the disease itself; and also mentions the degree of disability and stigma associated with migraine is ramped.

An editorial is presented that discussed about the development of the Pediatric Migraine Action Plan (PedMAP) which was first introduced in February 2018. It mentions the MAP's essential elements of a plan including a specific headache diagnosis, a preventive treatment plan, a home acute treatment strategy.

An introduction is presented in which the editor discusses appointment of Serena Orr and Melissa Rayhill as Associate Editor of the periodical.

An introduction is presented in which the editor discusses articles in the issue on topics including acute treatment of migraine attacks, use of target calcitonin gene-related peptide (CGRP) for migraine, and clinical trials of 5HT-1F receptor agonists.

The article offers information on the understanding of myths and misperceptions of spontaneous intracranial hypotension (SIH). It discussed the understanding of the underlying pathogenesis of the condition, including the relatively seminal advance of identifying cerebrospinal fluid (CSF) venous fistulas as a cause of SIH also awareness of SIH is key to diagnosis.

An editorial is presented on the importance of studying comorbidities in migraine. Topics include the comorbidities has associated with migraine because it has the potential to give us greater insight into disease pathophysiology, the important studies have evaluated individual comorbidities associated with migraine and have been helpful in the identification of certain comorbidities, and the interplay of these many comorbidities in a given population because it can provide additional insights.

An introduction is presented for the articles of the periodical on topics including the Members Choice Award, improve care for patients and promoting the use of person-first language.

A review of the article "Headaches in brain tumor patients: Primary or secondary?" by S. Nelson and L.P. Taylor in a previous issue, is presented.

An introduction is presented in which the editor discusses various reports within the issue on topics including cannabinoids and hallucinogens, headache, and face pain.

The article offers the author's view on the Type 1 error rate in headache research. The author states that Type 1 error is the probability that null hypothesis is rejected when it is true. The author cites that the error sets a consistent threshold for judging the statistical inferences. The author also mentions the type of error sets which must be considered including pre-comparison, family wise, and experiment wise.

The article offers information on Headache Currents as a separate review entity or journal for the American Headache Society has had 3 editors across its lifetime since 2004. Topics include the concept of a separate journal for scientific and clinical reviews was championed and guided by David Dodick, and Wendy Krank has served as the Managing Editor for Headache Currents from its onset.

A personal narrative is presented which explores the author's experience of Headache Currents.

An editorial is presented which argues against Symposium of the Headache Cooperative of the Pacific held in Ojai, California in January of 2020.

The article announces the American Headache Society Early Career Lecture Award which is given to Dr. Russo and his co-authors; and Dr. Nazia Karsan and her co-authors.

Nausea is a defining feature of episodic migraine. Migraine-associated nausea can cause patients to delay or avoid taking oral medication. In April 2011, a round table of headache specialists and a gastroenterologist was convened to explore unmet needs in the treatment of migraine vis-à-vis gastrointestinal signs and symptoms. This supplement summarizes the proceedings of that roundtable meeting. [ABSTRACT FROM AUTHOR]

The author discusses whether or not functional magnetic resonance imaging (fMRI) is effective in providing some information on the pathophysiology of migraine. A study by Schwedt and colleagues in the current issue attempts to provide a better understanding of brain mechanisms underlying chronic migraine. He suggests that restingstate functional connectivity MRI (rs-fcMRI) has been found to provide an exciting avenue for future research as it is entirely noninvasive.

The author reflects on the headache triggers. She states that clinical practitioners use prospective assessment of covariation with potential triggers and headaches tracked in a diary which may be insufficient to identify reliable and valid headache triggers. There is a necessity to involve methodology and statistics experts in the early phases of research. Author suggests that headache researchers and clinicians should use caution when assigning the label of "trigger".

The article focuses on the enhanced online presence of the journal "Headache." Particular focus is given to the goal of the journal's online presence. It notes that short interviews with authors of key papers in article-based podcasts can be accessed by readers from the journal homepage. As of May 2011, the website has released eight podcasts, which is also available from the iTunes podcast store. It adds that the patient education pages of the site are available in Spanish and Portuguese.

The article announces the winners of the latest American Headache Society Members' Choice Award, including Clarimar Borrero-Mejias , Amaal J. Starling; and Rebecca Burch.

The article discusses issue of headache contains several articles of significance. Topics include Gretchen Tietjen that encapsulates her work on stroke and migraine in women; these pearls suggest telehealth visits and give options for acute, "bridge" and preventive therapies which would not require in person implementation; and the first recipient of an important new award from the American Headache Society.

The article announces the upcoming American Headache Society (AHS) Members' Choice Award for the Best Article in Headache.

The article present appointment of Dr. Chia-Chun Chiang, as an assistant editor at Mayo Clinic Arizona, Arizona.